The proposed study is designed to assess the effectiveness of treatment with Oxcarbazepine vs. placebo in childhood/adolescent autism. This is a twelve-week study involving twenty subjects between the ages of five and seventeen with a diagnosis of autism.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Vineland Adaptive Behavior Scales
Timeframe: Evaluated during Baseline and Termination
Aberrant Behavior Checklist
Timeframe: Bi weekly
Autism Diagnostic Observation Schedule
Timeframe: Evaluated during Baseline and Termination
Clinical Global Impression Improvement (CGI-AD)
Timeframe: Administered weekly Administered weekly